Resultados de búsqueda - "cirrhosis"

Position statement on the use of albumin in liver cirrhosis por Castro Narro, Graciela, Moctezuma Velázquez, Carlos, Male Velázquez, Rene, Trejo Estrada, Rafael, Bosques Padilla, Francisco Javier, Moreno Alcántar, Rosalba, Rodríguez Hernández, Heriberto, Bautista Santos, Aleida, Cortez Hernández, Carlos Alejandro, Cerda Reyes, Eira, Pérez Escobar, Juanita, Aldana Ledesma, Juan Manuel, Aguirre Valadez, Jonathan, Ruiz Velasco, José Antonio Velarde, Contreras Omaña, Raul, Miranda Zazueta, Godolfino, Reyes Bastidas, Monica del Rocío, Meza Cardona, Javier Manuel, Chávez Tapia, Norberto C., Fernández Pérez, Nicolas Joaquín, García Jiménez, Edgar Santino, Torre Delgadillo, Aldo

“…Cirrhosis is characterized by a prolonged asymptomatic period in which the inflammation persists, increasing as the disease progresses. …”
Enlace del recurso

Algorithm for Screening of Adrenal Function in Stable Patients with Cirrhosis por Paz Delgadillo, Jonathan, Monreal Robles, Roberto, Villarreal Pérez, Jesús Zacarías, Lavalle González, Fernando Javier, Maldonado Garza, Héctor Jesús, Bosques Padilla, Francisco Javier

“…AI) is common in patients with cirrhosis. We aimed to assess the presence of AI in stable patients with cirrhosis using the gold-standard insulin tolerance test (ITT) and to propose an algorithm for screening AI in these patients. …”
Enlace del recurso

Subclinical abnormal glucose tolerance is a predictor of death in liver cirrhosis por García Compeán, Diego, Jáquez Quintana, Joel Omar, Lavalle González, Fernando Javier, González González, José Alberto, Muñoz Espinosa, Linda Elsa, Villarreal Pérez, Jesús Zacarías, Maldonado Garza, Héctor Jesús

“…AIM: To determine if subclinical abnormal glucose tolerance (SAGT) has influence on survival of non-diabetic patients with liver cirrhosis. METHODS: In total, 100 patients with compensated liver cirrhosis and normal fasting plasma glucose were included. …”
Enlace del recurso

Diabetic myonecrosis in a patient with hepatic cirrhosis: a case report and review of the literature por Mancillas Adame, Leonardo Guadalupe, González González, José Gerardo, Jáquez Quintana, Joel Omar, Cardoza Torres, Myrna A., García, Alberto de la Fuente

“…Conclusion: To the best of our knowledge, this is the first case of diabetic myonecrosis associated with and complicated by advanced hepatic cirrhosis reported in the literature.…”
Enlace del recurso

Nonvariceal upper gastrointestinal bleeding in patients with liver cirrhosis. Clinical features, outcomes and predictors of in-hospital mortality.... por González González, José Alberto, García Compeán, Diego, Vázquez Elizondo, Genaro, Garza Galindo, Aldo, Jáquez Quintana, Joel Omar, Maldonado Garza, Héctor Jesús

“…In-hospital mortality of these patients seemed to be greater than that of non-cirrhotic patients, and it was significantly related to cryptogenic etiology of cirrhosis, renal dysfunction, severe hepatic failure, and active bleeding ulcers on admission to the hospital.…”
Enlace del recurso

Hepatogenous diabetes. Current views of an ancient problem por García Compeán, Diego, Jáquez Quintana, Joel Omar, Maldonado Garza, Héctor Jesús

“…Diabetes developed as a complication of cirrhosis is known as «hepatogenous diabetes» (HD). …”
Enlace del recurso

Advantages of adipose tissue stem cells over CD34+ mobilization to decrease hepatic fibrosis in Wistar rats por De Luna Saldivar, Marcela M., Marino Martínez, Iván Alberto, Franco Molina, Moisés Armides, Rivera Morales, Lydia Guadalupe, Alarcón Galván, Gabriela, Cordero Pérez, Paula, Rojas Martínez, Augusto, Rodríguez Padilla, Cristina, Muñoz Espinosa, Linda Elsa

“…Introduction and Objectives: Chronic liver inflammation may lead to hepatic cirrhosis, limiting its regenerative capacity. The clinical standard of care is transplantation, although stem cell therapy may be an alternative option. …”
Enlace del recurso

Interferon-based therapy delays but metabolic comorbidity accelerates progression of chronic hepatitis C por Martínez Macías, Roberto F., Cordero Pérez, Paula, Juárez Rodríguez, Omar A., Chen López, Carlos Y., Martínez Carrillo, Francisco M., Alarcón Galván, Gabriela, Mercado Hernández, Roberto, Muñoz Espinosa, Linda Elsa

“…Stepwise discriminant analysis showed that diabetes, high blood pressure, and no retreatment predicted cirrhosis development (eigenvalue ≥ 0.8; p < 0.05). …”
Enlace del recurso

Profile of pro and anti-inflammatory cytokines in patients with chronic liver disease in the compensation, inflammation and immunosuppression phases por Tijerina Soto, Bertha Patricia, Cordero Pérez, Paula, Moreno Peña, Diana Patricia, Treviño García, C., Muñoz Espinosa, Linda Elsa

“…Introduction and objectives: Decompensated cirrhosis is defined by the onset of complications and is associated with immune dysfunction. …”
Enlace del recurso

Hepatogenous diabetes: Is it a neglected condition in chronic liver disease? por García Compeán, Diego, González González, José Alberto, Lavalle González, Fernando Javier, González Moreno, Emmanuel Irineo, Villarreal Pérez, Jesús Zacarías, Maldonado Garza, Héctor Jesús

“…Although the association of diabetes and liver cirrhosis was described forty years ago, it was scarcely studied for long time. …”
Enlace del recurso

Experimental models for hepatitis C virus (HCV): New opportunities for combating hepatitis C por Trujillo Murillo, Karina del Carmen, Garza Rodríguez, María de Lourdes, Martínez Rodríguez, Herminia Guadalupe, Barrera Saldaña, Hugo Alberto, Bosques Padilla, Francisco Javier, Ramos Jiménez, Javier, Rivas Estilla, Ana María

“…Hepatitis C is considered one of the main causes of chronic hepatitis, cirrhosis, hepatocellular carcinoma and liver transplantation. …”
Enlace del recurso

Differences in the presentation and treatment of primary liver tumors at a hepatology center and an oncology center por Rojas Pintor, K.P., Arizmendi Villarreal, M.A., Aparicio Salas, J.E., Moreno Peña, Diana Patricia, Hernández Barajas, David, Cordero Pérez, Paula, Muñoz Espinosa, Linda Elsa

“…Results: Of the total population, 93% (n = 102) presented with cirrhosis, 86% (n = 94) had HCC (HC: 58%, UCAC: 42%), and 14% (n = 15) had intrahepatic CC (HC: 40%, UCAC: 60%). …”
Enlace del recurso

Treatment of cirrhotic tense ascites with Dextran-40 versus albumin associated with large volume paracentesis: a randomized controlled trial por García Compeán, Diego, Blanc, Pierre, Larrey, Dominique, Daures, Jean-Pierre, Hirtz, Jacques, Mendoza, Eduardo, Maldonado, Héctor, Michel, Henri

“…Patients were followed up for the detection of any recurrence of ascites or complications.The two groups were similar in age, sex, and etiology of cirrhosis, and in the volumes of ascites recovered. …”
Enlace del recurso

Acute Variceal Bleeding: Does Octreotide Improve Outcomes in Patients with Different Functional Hepatic Reserve? por Monreal Robles, Roberto, Cortez Hernández, Carlos Alejandro, González González, José Alberto, Abraldes, Juan G., Bosques Padilla, Francisco Javier, Silva Ramos, Héctor Noé Guadalupe, García Flores, Jorge A., Maldonado Garza, Héctor Jesús

“…Current guidelines do not differentiate in the utilization of vasoactive drugs in patients with cirrhosis and acute variceal bleeding (AVB) depending on liver disease severity. …”
Enlace del recurso

Asociación Mexicana de Hepatología A.C. Guía Clínica de Hepatitis B por Higuera de la Tijera, María de Fátima, Castro Narro, Graciela, Velarde Ruiz Velasco, José Antonio, Cerda Reyes, Eira, Moreno Alcántar, Rosalba, Aiza Haddad, Ignacio, Castillo Barradas, M., Cisneros Garza, Laura Esthela, Dehesa Violante, Margarita, Flores Calderón, J., González Huezo, M. S., Márquez Guillén, E., Muñoz Espinosa, Linda Elsa, Pérez Hernández, J. L., Ramos Gómez, Mayra Virginia, Sierra Madero, J., Sánchez Ávila, Juan F., Torre Delgadillo, Adriana, Torres Zapata, Raúl, Marín López, E.R., Kershenobich, D., Wolpert Barraza, Enrique

“…Semi-annual liver ultrasound and serum alpha-fetoprotein testing favor early detection of that cancer and should be carried out in all patients with chronic HBV infection, regardless of the presence of advanced fibrosis or cirrhosis. Currently, nucleoside/nucleotide analogues that have a high barrier to resistance are the first-line therapies.…”
Enlace del recurso

Plasma cytokine levels imbalance in cirrhotic patients with impaired glucose tolerance and diabetes mellitus: a prospective study por García Compeán, Diego, Jáquez Quintana, Joel Omar, Lavalle González, Fernando Javier, González González, José Alberto, Maldonado Garza, Héctor Jesús, Villarreal Pérez, Jesús Zacarías

“…To define if there is an imbalance in plasma levels of proinflammatory, fibrogenic and antifibrogenic cytokines in patients with liver cirrhosis (LC) and impaired glucose tolerance (IGT) or diabetes mellitus (DM). …”
Enlace del recurso

The Mexican consensus on alcoholic hepatitis por Velarde Ruiz Velasco, José Antonio, Higuera de la Tijera, María de Fátima, Castro Narro, Graciela, Zamarripa Dorsey, F., Abdo Francis, J.M., Haddad, I. Aiza, Aldana Ledesma, Juan Manuel, Bielsa Fernández, María Victoria, Cerda Reyes, Eira, Cisneros Garza, Laura Esthela, Contreras Omaña, Raul, Reyes Dorantes, A., Fernández Pérez, Nicolas Joaquín, García Jiménez, Edgar Santino, Icaza Chávez, M. E., Kershenobich Stalnikowitz, David, Lira Pedrín, M.A., Moreno Alcántar, Rosalba, Pérez Hernández, J. L., Ramos Gómez, Mayra Virginia, Rizo Robles, M.T., Solana Sentíes, S., Torre Delgadillo, Adriana

“…Alcohol-related liver disease covers a broad spectrum of patholo-gies that includes steatosis, steatohepatitis, different grades of fibrosis, and cirrhosis and itscomplications. Severe alcoholic hepatitis is defined by a modified Maddrey’s discriminant func-tion score ≥ 32 or by a Model for End-Stage Liver Disease (MELD) score equal to or above 21.There is currently no specific biomarker for its diagnosis. …”
Enlace del recurso

Evaluation of IL-12 and CXCL-10 in patients with hepatitis C, non-alcoholic fatty liver disease and liver damage for alcohol consumption por Hernández Santillan, M., Martínez Castillo, M., Medina Avila, Z., Lemus Peña, M, Montes de Oca Ángeles, D, Hernández Barragán, A., Pérez Hernández, J. L., Higuera de la Tijera, María de Fátima, Santana Vargas, D., Cordero Pérez, Paula, Muñoz Espinoza, Linda, Córdova Gallardo, J., Kershenobich Stalnikowitz, David, Gutiérrez Reyes, Gabriela

“…Materials and methods: A cross-sectional and multicenter study was carried out, including subjects with alcoholism according to criteria WHO, without (OH) and with liver injury (cirrhosis, CiOH) and (Alcoholic Hepatitis, HA); non-alcoholic fatty liver (NAFLD) and chronic Hepatitis C (CHC), diagnosed by clinical, biochemical data. …”
Enlace del recurso

Sofosbuvir-velpatasvir en pacientes mexicanos con hepatitis C: una revisión retrospectiva por Pérez Hernández, J. L., Arce Salinas, C.A., Lehmann Mendoza, R., Torre Delgadillo, Adriana, Castro Narro, Graciela, Cerda Reyes, Eira, Ramos Gómez, Mayra Virginia, Juárez Chávez, Leonardo, Dehesa Violante, Margarita, Muñoz Espinosa, Linda Elsa, Cisneros Garza, Laura Esthela, Aiza Haddad, Ignacio, Velarde Ruiz Velasco, José Antonio, Contreras Omaña, Raul, García Casarreal, Nancy, Carmona Castañeda, A., Higuera de la Tijera, María de Fátima

“…Only three patients did not achieve SVR, two of whom had cirrhosis and a history of previous treatment with peg-IFN. …”
Enlace del recurso

Inhibición de la replicación y expresión de un replicón subgenómico del virus de la hepatitis c, con RNA’S de interferencia por Elizondo González, Regina

“…Abstract The Infection with Hepatitis C virus (HCV) is a worldwide public health problem and it is considered as one of the main causes of chronic hepatitis, cirrhosis and hepatocellular carcinoma. Approximately 1.2% of the population in Mexico is infected with HCV. …”
Enlace del recurso